Global Skin Cancer Diagnostics Market Research Report To 2018 Added By DecisionDatabases


(MENAFNEditorial) iCrowdNewswire - Dec 14, 2017

DecisionDatabases recently added the fact-findings of Worldwide Skin Cancer Diagnostics Market Report that gives the potential value of the market providing business strategists with the latest growth opportunities covers the complete competitive landscape of the global market with company profiles of key players as all as evaluates the prospective market size, share, trends and growth in the coming years.

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin cancers. The major cause of skin cancer is exposure to ultraviolet (UV) rays from the sun. There are three major types of skin cancers as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. The first two skin cancers are grouped together as non-melanoma skin cancers. Other unusual types of skin cancer include Merkel cell tumors and dermatofibrosarcoma protruberans.

The increasing incidences of melanoma and non-melanoma skin cancer, technological advancements, availability of number of diagnostic products are some of the major drivers of skin cancer diagnostics market. However, requirement of large capital investment and limited patient base are the restraining factors of the global skin cancer diagnostics market. Furthermore, lack of competition for these products in high potential market creates an opportunity for this market.

Get FREE Sample Copy Of this Report @

The market is segmented into by type of cancer, by products, and by geography. The global skin cancer diagnostics market by type of cancer is segmented into basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. By products, the market is segmented into dermatoscopes, microscopes, imaging techniques, and optical coherence tomography scanners. The global skin cancer diagnostics market be geography is segmented as North America, Europe, Asia, and Rest of World (RoW).

The major market drivers are Increasing incidence of melanoma and non-melanoma skin cancer, Technological advancements, Imaging techniques offers the confirmatory diagnostic tests and Product differentiation to drive growth and prevent threat of substitutes. The market growth might be restricted due Increased investments & other initiatives and Limited patient base under the study period.

Some of the major players of global nephrology and urology devices market include Agilent Technologies, Inc., Biolitech AG, GE Healthcare, Leica Microsystems, Michelson Diagnostics Ltd., and Toshiba Medical Systems.

View More:http://www.decisiondatabases.com/ip/420-skin-cancer-diagnostics-market-report

Other Related Market Research Reports By DecisionDatabases

Global Neurorehabilitation System Market Research Report - Industry Analysis and Forecast

Theglobal neurorehabilitation systems market is expected to grow at a healthy CAGR during the forecast period of 2013 to 2018. Rising incidences of neurological disorders, growing need of automated monitoring and assessing activities of nervous systems, rising need to ensure improved treatment outputs are some of the major factors driving the growth of the neurorehabilitation systems market. -See more at

Global Soft Tissue Repair Market Research Report - Industry Analysis and Forecast

Theglobal soft tissue repair marketis expected to grow with moderate CAGR during the forecast period of 2013 to 2018. The factors such as availability of technologically advanced products in the market, and rising number of incidences of tissue damage and injury are expected to drive this market during forecast period. The developing economies in the Asia and Latin American region such as China, India and Brazil are expected to have high growth potential and greater opportunity for the growth of the soft tissue repair market. - See more at

For more information, write to us at

Contact Information:

3rd Floor, Fountain chambers,
Nanabhai Lane, Fort, Mumbai - 1
E-Mail:
Phone: +91 99 28 237112
Web: www.decisiondatabases.com

MENAFN1412201700703403ID1096231789


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.